Unihealth Consultancy Ltd

Unihealth Consultancy Ltd

₹ 147 1.62%
22 Nov 10:32 a.m.
About

Incorporated in 2010, Unihealth Consultancy Ltd is in the business of Medical Tour Operator and Health Consultancy Service & Trader in Medical Equipments[1]

Key Points

Business Overview:[1]
a) UHCL is an ISO 9001:2015 certified healthcare service provider with a global presence, especially in Africa.
b) The company operates medical centers and hospitals, provides consultancy services, distributes pharmaceutical and medical consumable products, and offers medical value travel.
c) UHCL is involved in healthcare consultancy projects in India and various African countries, and exports and distributes pharma and medical consumable products to Uganda, Tanzania, and Nigeria.
d) It acts as a distributor for several Indian manufacturers in these African nations.
e) The company has 4 centers and 2 hospitals, with over 150 doctors and specialists treating more than 1.10 lakh patients annually.
f) UHCL manages two multi-specialty facilities with a total of 200 operational beds and has over 1,200 beds in projects under consultancy.

  • Market Cap 226 Cr.
  • Current Price 147
  • High / Low 178 / 109
  • Stock P/E 20.1
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 20.2 %
  • ROE 18.2 %
  • Face Value 10.0

Pros

  • Company has reduced debt.

Cons

  • Company has high debtors of 251 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Mar 2024 Sep 2024
22 27 24
15 16 16
Operating Profit 7 10 8
OPM % 32% 39% 33%
1 1 1
Interest 2 2 1
Depreciation 1 1 1
Profit before tax 5 8 7
Tax % 17% 28% 29%
4 6 5
EPS in Rs
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
22 26 37 44 49 50
20 20 25 30 31 32
Operating Profit 2 7 12 14 18 18
OPM % 10% 25% 31% 31% 36% 37%
1 2 1 2 2 2
Interest 2 1 5 4 3 3
Depreciation 2 2 2 3 2 2
Profit before tax -1 5 5 9 14 16
Tax % 2% 9% 27% 17% 24%
-1 5 4 8 10 11
EPS in Rs
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 23%
TTM: 11%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 28%
TTM: 35%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 5%
Return on Equity
10 Years: %
5 Years: %
3 Years: 24%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 1 1 1 1 15 15
Reserves 4 9 13 26 70 77
41 39 38 39 15 10
12 9 12 12 10 11
Total Liabilities 58 58 65 78 110 113
35 35 36 37 36 37
CWIP 2 0 0 0 0 1
Investments 0 0 0 0 0 0
20 22 28 41 74 75
Total Assets 58 58 65 78 110 113

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1 4 9 1 5
-1 0 -3 -5 0
1 -3 -6 3 22
Net Cash Flow 0 1 0 -0 27

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 206 198 180 228 251
Inventory Days 50 86 78 98 88
Days Payable 382 91 79 137 104
Cash Conversion Cycle -125 192 180 188 235
Working Capital Days 114 162 146 170 228
ROCE % 14% 20% 22% 20%

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2023Mar 2024Sep 2024
68.80% 68.80% 68.93%
5.61% 0.00% 0.00%
3.31% 0.14% 0.02%
22.27% 31.05% 31.05%
No. of Shareholders 1,111979984

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents